Beneficial Effects of Nano-sized Bee Pollen on Testosterone-induced Benign Prostatic Hyperplasia in Rodents
![]() |
Bak, Jia
(Department of Pharmacy, Kyungsung University)
Pyeon, Hae-In (Department of Pharmacy, Kyungsung University) So, Soojeong (Research Center, Natural Science Biotechnology Co., Ltd.) Lee, Seunghyun (Department of Biotechnology, Daegu Catholic University) Lee, Seungmin (Research Center, Natural Science Biotechnology Co., Ltd.) Suh, Hwa-Jin (Research Center, Natural Science Biotechnology Co., Ltd.) Kang, Jae Seon (Department of Pharmacy, Kyungsung University) Choi, Yun-Sik (Department of Pharmacy, Kyungsung University) Chung, Il Kyung (Department of Biotechnology, Daegu Catholic University) |
1 | Komosinska-Vassev, K., Olczyk, P., Kazmierczak, J., Mencner, L. and Olczyk, K. 2015. Bee pollen: chemical composition and therapeutic application. Evid. Based Complement Alternat. Med. 2015, 297425. |
2 | MacDonald, R., Ishani, A., Rutks, I. and Wilt, T. J. 2000. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int. 85, 836-841. |
3 | McNicholas, T. and Kirby, R. 2011. Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). BMJ Clin. Evid. 26, 2011. |
4 | Morais, M., Moreira, L., Feás, X. and Estevinho, L. M. 2011. Honeybee-collected pollen from five Portuguese Natural Parks: Palynological origin, phenolic content, antioxidant properties and antimicrobial activity. Food Chem. Toxicol. 39, 1096. |
5 | Nickel, J. C. 2006. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr. Opin. Urol. 16, 5-10. DOI |
6 | Pyeon, H. I., Bak, J., Seok, J. I., So, S., Suh, H. J., Oh, M., Kim, S., Yang, C. E., Chung, I. K. and Choi, Y. S. 2017. Effects of nano-sized bee pollen as a new cosmetic ingredient. Asian J. Beauty Cosmetol. 15, 1-9. DOI |
7 | Swaroop, A., Bagchi, M., Kumar, P., Preuss, H. G. and Bagchi, D. 2015. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats. Toxicol. Mech. Methods 25, 653-664. DOI |
8 | Ulbricht, C., Conquer, J., Giese, N., Khalsa, K. P., Sklar, J., Weissner, W. and Woods, J. 2009. An evidence-based systematic review of bee pollen by the Natural Standard Research Collaboration. J. Diet Suppl. 6, 290-312. DOI |
9 | Van Asseldonk, B., Barkin, J. and Elterman, D. S. 2015. Medical therapy for benign prostatic hyperplasia: a review. Can. J. Urol. 22, Suppl 1:7-17. |
10 | Wu, Y. D. and Lou, Y. J. 2007. A steroid fraction of chloroform extract from bee pollen of Brassica campestris induces apoptosis in human prostate cancer PC-3 cells. Phytother. Res. 21, 1087-1091. DOI |
11 | Buck, A. C. 1996. Phytotherapy for the prostate. Br. J. Urol. 78, 325-326. DOI |
12 | Ares, A. M., Valverde, S., Bernal, J. L., Nozal, M. J. and Bernal, J. 2018. Extraction and determination of bioactive compounds from bee pollen. J. Pharm. Biomed. Anal. 147, 110-124. DOI |
13 | Baltrusaityte, V., Venskutonis, P. R. and Ckstaryte, V. 2007. Radical scavenging activity of different floral origin honey and beebread phenolic extracts. Food Chem. 101, 502. DOI |
14 | Bogdanov, S. 2015. Pollen: production, nutrition and health: A review. www.bee-hexagon.net. |
15 | Kim, S. B., Jo, Y. H., Liu, Q., Ahn, J. H., Hong, I. P., Han, S. M., Hwang, B. Y. and Lee, M. K. 2015. Optimization of extraction condition of bee pollen using response surface methodology: correlation between anti-melanogenesis, antioxidant Activity, and phenolic content. Molecules 20, 19764-19774. DOI |
16 | Choi, Y. S., Suh, H. J. and Chung, I. K. 2016. Enhanced extraction of bioactive compounds from bee pollen by wetgrinding technology. J. Life Sci. 6, 651-656. |
17 | Cohen, S. A. and Parsons, J. K. 2012. Combination pharmacological therapies for the management of benign prostatic hyperplasia. Drugs Aging 29, 275-284. DOI |
18 | Cordaro, M., Impellizzeri, D., Siracusa, R., Gugliandolo, E., Fusco, R., Inferrera, A., Esposito, E., Di Paola, R. and Cuzzocrea, S. 2017. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia. Toxicol. Appl. Pharmacol. 329, 231-240. DOI |
![]() |